Tus kws kho mob
P60-19 New Reimbursement Policy for Bundled Services
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2721 - 2730 ntawm 3679
Tus kws kho mob
QP60-19 2019 Blue Cross Basic Seminars
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP61-19 Availity Portal Authorization Frequently Asked Questions
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
P55-19 Change to Prior Authorization Requirements for Radiology Program for Fully Insured Commercial and Medicare Advantage Subscribers-eviCore HealthCare Specialty Utilization Management Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2019
Tus kws kho mob
P501R1-19 Update: Provider Telephone Number Added – Change to TPA Business and Submitting claims for TPA Plan Members
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2019
Tus kws kho mob
P53-19 New Medical, Medical Drug and Behavioral health Policy Management Updates – Effective August 5, 2019
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2019
Tus kws kho mob
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP59-19 eviCore Group Number List to be Removed
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019